🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, open-label Phase 0 Master Protocol in Australia des...
Status
Withdrawn
Location
Chris O'Brien Lifehouse
Start Date
2021-09-15
Trial ID
NCT04891718
Treatments Being Tested
This is a multi-center, single arm, open-label, multi-agent, localized phar...
Status
Completed
Location
University of Michigan
Start Date
2020-10-07
Trial ID
NCT04065555
Treatments Being Tested
The purpose of the study is to examine the safety of a 14 day infusion of s...
Status
Completed
Location
University of Virginia Health System Medical Center
Start Date
2010-04
Trial ID
NCT00873015
Treatments Being Tested
Lesions of herpes labialis are caused by the herpes simplex virus type 1 (H...
Status
Completed
Location
Anna Carolina R.T. Horliana
Start Date
2020-01-01
Trial ID
NCT04037475
Treatments Being Tested
This is a single center, double-blinded, randomized, placebo controlled sin...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2022-06-06
Trial ID
NCT06769620
The objective of this study is to assess the safety and biologic activity o...
Status
Completed
Location
Tufts Medical Center, Department of Dermatology
Start Date
2008-11
Trial ID
NCT00929578
Treatments Being Tested
This is a prospective, single-blinded, single-center, randomized, comparati...
Status
Unknown
Location
N.V. Sklifosovsky Emergency Care Institute
Start Date
2022-12-05
Trial ID
NCT05693181
This is a multi-center, single arm, open-label, localized pharmacodynamic b...
Status
Recruiting
Location
LSU Health Sciences Center
Start Date
2025-03-27
Trial ID
NCT06700070
Treatments Being Tested
Plasmin is expected to create a posterior vitreous detachment. The pharmaco...
Status
Terminated
Location
Emory University
Start Date
2006-04
Trial ID
NCT00348439
This is a multi-center, open-label, Phase 0 substudy designed to evaluate t...
Status
Completed
Location
UC Davis
Start Date
2022-06-01
Trial ID
NCT06413095
Treatments Being Tested